Supplementary Financial Results Information for the Fiscal Year Ending March 2026 | SHIP HEALTHCARE HOLDINGS,INC. (3360) timely disclosure

Worth reading

44Recurring

0–100. This measures how worthwhile something is to read, not how good or bad the company is.

Direction

Mixed performance

Direction inferred from the company’s description.

Scale

39933

¥ million (year-on-year increase in net sales)

Wording

Conditional

How definitive the wording is.

Contents of this document

Supplementary materials to the earnings reportFiscal year ending March 2026, full year7 items taken from the company’s own explanation

Financial Results Figures (The key points of this material are explained below)

Net Sales¥718,163 million+5.9%

Operating profit¥24,482 million-1.2%

Ordinary income¥26,331 million+1.2%

Net income¥13,394 million-11.5%

Operating profit margin3.4 %

Full-year earnings forecast

Net Sales

¥740,000 million

Operating profit

¥26,000 million

Ordinary income

¥26,500 million

Profit attributable to owners of the parent

¥16,000 million

Earnings per share

¥173.88

Dividend per share

¥65

What the company explained in this material

Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.

Increase in SG&A expenses due to the expansion of the scope of companies subject to the size-based enterprise tax

¥800 million

New initiatives

Start of operations at 5 new outsourced SPD facilities
Launch of SPD projects under blanket contracts with multiple hospitals
Start of operations at a medical supplies logistics facility in the Tokyo metropolitan area
Withdrawal from kitchen operations at unprofitable facilities or conversion to Dream Kitchen operations
Integration of 4 companies in the PH business and closure or consolidation of 5 unprofitable stores

Key KPIsA metric the company considers important as a management benchmark.

Number of outsourced SPD facilities277 Engagements
Number of beds covered by outsourced SPD services102,000 beds
Number of PH stores129 Location
Year on year against the same period last year+7 stores from the end of the previous fiscal year

Segment results

Total Pack Produce Business (TPP)

Net Sales

¥136,604 million+2.6%

Operating profit

¥10,812 million-10.0%

Medical Supply Business (MSP)

Net Sales

¥509,569 million+7.3%

Operating profit

¥7,484 million+7.4%

Life Care Business (LC)

Net Sales

¥37,322 million+1.8%

Operating profit

¥2,216 million+1.2%

Dispensing Pharmacy Business (PH)

Net Sales

¥34,666 million+3.6%

Operating profit

¥4,004 million+16.9%

Number of stores and locations

Number of PH stores

End of period129 Location

Openings and closures during the period5 stores closed or consolidated, and 5 stores joined the Group

MSP medical supplies logistics facilityA new medical supplies logistics facility began operations in the Tokyo metropolitan area

Annual Dividend

Fiscal year ending March 2026

Annual¥60 per share

Forecast for the fiscal year ending March 2027

Annual¥65 per share

Payout ratio

Fiscal year ending March 202641.6 %

Forecast for the fiscal year ending March 202737.4 %

Contents of this document
Item	Details
Document type	Supplementary materials to the earnings report
Fiscal Period Covered	Fiscal year ending March 2026, full year
Net Sales	¥718,163 million (YoY +5.9%)
Operating profit	¥24,482 million (YoY -1.2%)
Ordinary income	¥26,331 million (YoY +1.2%)
Net income	¥13,394 million (YoY -11.5%)
Operating profit margin	3.4 %
Full-year earnings forecast	Net Sales ¥740,000 million / Operating profit ¥26,000 million / Ordinary income ¥26,500 million / Profit attributable to owners of the parent ¥16,000 million / Earnings per share ¥173.88 / Dividend per share ¥65
Segment results	Total Pack Produce Business (TPP) Net Sales ¥136,604 million (YoY +2.6%) / Operating profit ¥10,812 million (YoY -10.0%) / Medical Supply Business (MSP) Net Sales ¥509,569 million (YoY +7.3%) / Operating profit ¥7,484 million (YoY +7.4%) / Life Care Business (LC) Net Sales ¥37,322 million (YoY +1.8%) / Operating profit ¥2,216 million (YoY +1.2%) / Dispensing Pharmacy Business (PH) Net Sales ¥34,666 million (YoY +3.6%) / Operating profit ¥4,004 million (YoY +16.9%)
Key KPIs	Indicator name Number of outsourced SPD facilities / Value 277 Engagements / Year on year against the same period last year Not disclosed, Indicator name Number of beds covered by outsourced SPD services / Value 102,000 beds / Year on year against the same period last year Not disclosed, Indicator name Number of PH stores / Value 129 Location / Year on year against the same period last year +7 stores from the end of the previous fiscal year
Number of stores and locations	Number of PH stores End of period 129 Location / Openings and closures during the period 5 stores closed or consolidated, and 5 stores joined the Group / MSP medical supplies logistics facility A new medical supplies logistics facility began operations in the Tokyo metropolitan area
Assumptions Underlying the Business Outlook	Increase in SG&A expenses due to the expansion of the scope of companies subject to the size-based enterprise tax ¥800 million
Annual Dividend	Fiscal year ending March 2026 Annual ¥60 per share / Interim Not disclosed / End of period Not disclosed / Forecast for the fiscal year ending March 2027 Annual ¥65 per share / Interim Not disclosed / End of period Not disclosed
Payout ratio	Fiscal year ending March 2026 41.6 % / Forecast for the fiscal year ending March 2027 37.4 %
New initiatives	Start of operations at 5 new outsourced SPD facilities, Launch of SPD projects under blanket contracts with multiple hospitals, Start of operations at a medical supplies logistics facility in the Tokyo metropolitan area, Withdrawal from kitchen operations at unprofitable facilities or conversion to Dream Kitchen operations, Integration of 4 companies in the PH business and closure or consolidation of 5 unprofitable stores

Items this document does not state (16)

Gross Profit MarginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue benefited from the recognition of large-scale projects, the contribution of an ODA specialist trading company that joined the Group in May 2025, the start of operations at 5 new outsourced SPD facilities, and the launch of SPD projects under blanket contracts with multiple hospitals. Operating profit was affected by the absence this fiscal year of the completion and sale of a condominium development for seniors recorded in the previous fiscal year, delays in the delivery of materials, higher component prices and production delays, increases in utilities and personnel expenses, and one-time costs including M&A fees. Ordinary income reflected a decline in equity-method investment gains, while foreign exchange gains were recorded as a result of the weaker yen.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.